These PMGs, namely CLDN6, CES1, SOST, SPRR2A, CRTAC1, DSG3, MYBPH, CGB5, and KRT1, held considerable promise in predicting the prognosis of BLCA patients. Here, SOST is linked to bladder transitional cell carcinoma.